Professor Kevin Shakesheff has been appointed as the new Interim Chair of the One Nottingham Board taking over from Jane Todd, who stood down earlier this year.
Kevin is Pro-Vice Chancellor for Science at the University of Nottingham and Chief Scientific Officer at Locate Therapeutics Ltd., a company developing new medicines and medical devices for orthopaedic surgery. He is also a board member of the Biocity Group Nottingham. Kevin joined the One Nottingham board to help the University play its role in promoting Nottingham as a leading city for research, teaching, culture and job creation. He will be leading One Nottingham through coming months as it reviews its plans and partnership arrangements.